The effects of valproate on intermediary metabolism in isolated rat hepatocytes and intact rats

Biochemical Pharmacology
D M TurnbullH S Sherratt

Abstract

Valproate is a valuable anticonvulsant which is associated with hepatotoxicity in some patients. In concentrations in the range found in man during valproate therapy (0.1-1.0 mM), it inhibited pyruvate and palmitate oxidation, urea synthesis and gluconeogenesis by 30-50% in isolated rat hepatocytes. Valproate (100 mg/kg body weight) is also hypoglycaemic and hypoketonaemic in fasted rats. All these inhibitions can be explained in terms of the accumulation of valproyl-CoA and its further metabolites in the matrix of hepatic mitochondria. Although these inhibitions are only partial, and normally well tolerated, they could significantly impair liver function when there is an additional insult, such as may occur with multiple drug therapy or if there is already an inborn error of metabolism. Such an association with inborn errors may explain the higher incidence of valproate-associated toxicity in children. It may be of more value to measure blood urea and ammonia concentrations routinely shortly after starting valproate therapy than to do conventional liver function tests.

References

Jan 17, 1977·Clinica Chimica Acta; International Journal of Clinical Chemistry·D GompertzT Baillie
Jul 1, 1979·The Journal of Pediatrics·N GerberJ C Schimschock
Feb 1, 1977·Developmental Medicine and Child Neurology·P M JeavonsM C Maheshwari
Feb 28, 1975·European Journal of Clinical Pharmacology·F SchobbenF J Gabreëls
Aug 1, 1967·The Biochemical Journal·J F Chase
May 23, 1981·Lancet·J H TrippV G Oberholzer
Jan 1, 1981·Journal of Inherited Metabolic Disease·K BartlettJ V Leonard
Apr 1, 1980·Developmental Medicine and Child Neurology·G M Addison, N S Gordon
Sep 1, 1981·Neurology·S RawatH M Swick
Jan 1, 1982·Journal of Neurology, Neurosurgery, and Psychiatry·D M TurnbullD W Chadwick
Mar 1, 1982·Annals of Neurology·M L Batshaw, S W Brusilow
Apr 15, 1982·Biochemical Pharmacology·J BenavidesF Valdivieso
Jan 1, 1962·The Biochemical Journal·D H WILLIAMSONH A KREBS

❮ Previous
Next ❯

Citations

Jun 1, 1989·Metabolic Brain Disease·L Zieve, C Lyftogt
Jan 1, 1990·European Journal of Clinical Pharmacology·F M WilliamsM D Rawlins
Jan 1, 1984·Journal of Inherited Metabolic Disease·H S Sherratt, R K Veitch
Apr 9, 2008·Journal of Inherited Metabolic Disease·M F B SilvaI Tavares de Almeida
Nov 2, 1993·Biochimica Et Biophysica Acta·L Wojtczak, P Schönfeld
Oct 15, 1989·Biochemical Pharmacology·M CulebrasJ M López-Novoa
Nov 1, 1990·Biochemical Pharmacology·K Veitch, F Van Hoof
Jul 15, 1991·Biochemical Pharmacology·D M CyrG C Tremblay
Jan 1, 1995·Pharmacology & Therapeutics·B Fromenty, D Pessayre
Aug 1, 1990·Toxicology·R M WalkerG E Macallum
Jan 1, 1991·Toxicology in Vitro : an International Journal Published in Association with BIBRA·R FisherK Brendel
May 14, 2005·Free Radical Biology & Medicine·Vincent TongFrank S Abbott
Mar 7, 2002·The Biochemical Journal·Margarida F B SilvaRonald J A Wanders
Sep 1, 1986·Epilepsia·M C LaubG Jaeger
Jan 1, 1987·Epilepsia·N C Margaretten, R P Warren
Mar 1, 1987·Epilepsia·T SugimotoY Kobayashi
Sep 1, 1988·Epilepsia·M B TennisonR E Dupuis
Sep 1, 1994·Epilepsia·M A VanceK G Tolman
Apr 1, 1986·Journal of Neurology, Neurosurgery, and Psychiatry·D M TurnbullK G Alberti
Jul 27, 2011·PloS One·Nívea Dias AmoêdoFranklin David Rumjanek
Feb 22, 2001·Analytical Biochemistry·M F SilvaR J Wanders
Oct 25, 2013·Journal of Inherited Metabolic Disease·Paula B M LuísMargarida F B Silva
Sep 7, 2011·Drug Metabolism Reviews·Dominique PessayreAbdellah Mansouri
Mar 1, 1988·Medical Toxicology and Adverse Drug Experience·M J EadieR G Dickinson
Nov 1, 1988·Kidney International·M Rengel-ArandaJ M Lopez-Novoa
Aug 17, 2011·Biochemical Pharmacology·Paula B M LuísMargarida F B Silva
Nov 3, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Joanna D StewartPatrick F Chinnery
Mar 13, 2015·Developmental Medicine and Child Neurology·Ingrid Tein
Nov 1, 1984·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·A M JezequelF Orlandi
Jul 20, 1993·Biochemical Pharmacology·S Ponchaut, K Veitch

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.